Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Rheumatoid Arthritis

  Free Subscription


05.02.2024

1 Ann Rheum Dis
1 Clin Exp Rheumatol
9 Clin Rheumatol
3 J Rheumatol
1 Rheumatol Int


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Rheum Dis

  1. HU F, Shi L, Liu X, Chen Y, et al
    Proinflammatory phenotype of B10 and B10pro cells elicited by TNF-alpha in rheumatoid arthritis.
    Ann Rheum Dis. 2024 Feb 1:ard-2023-224878. doi: 10.1136/ard-2023-224878.
    PubMed         Abstract available


    Clin Exp Rheumatol

  2. DOBIES B, White AJ, Isberg A, Gudmundsson SF, et al
    Digital health program improves quality of life in rheumatoid arthritis: a retrospective analysis of real-world data.
    Clin Exp Rheumatol. 2024;42:10-14.
    PubMed         Abstract available


    Clin Rheumatol

  3. ZHANG L, Tan M, Mao J, Zhang J, et al
    Natural compound library screening to identify berberine as a treatment for rheumatoid arthritis.
    Clin Rheumatol. 2024 Feb 2. doi: 10.1007/s10067-024-06871.
    PubMed         Abstract available

  4. LERCARA A, Malattia C, Hysa E, Gattorno M, et al
    Microvascular status in juvenile Sjogren's disease: the first nailfold videocapillaroscopy investigation.
    Clin Rheumatol. 2024;43:733-741.
    PubMed         Abstract available

  5. ZHAO R, Dong C, Gu Z, Ding X, et al
    Development and validation of a nomogram for predicting fatigue in patients with primary Sjogren's syndrome.
    Clin Rheumatol. 2024;43:717-724.
    PubMed         Abstract available

  6. ZHOU X, Li H, Wang N, Jin Y, et al
    Respiratory infection risk in primary Sjogren's syndrome complicated with interstitial lung disease: a retrospective study.
    Clin Rheumatol. 2024;43:707-715.
    PubMed         Abstract available

  7. SHEN Y, Yu X, Wang Q, Yao X, et al
    Association between primary Sjogren's syndrome and gut microbiota disruption: a systematic review and meta-analysis.
    Clin Rheumatol. 2024;43:603-619.
    PubMed         Abstract available

  8. HUANG Y, Qiu Y, Xie Z, Zhang F, et al
    Risk factors and prognosis of interstitial lung disease for primary Sjogren syndrome patients: A retrospective case?control study.
    Clin Rheumatol. 2023;42:3033-3041.
    PubMed         Abstract available

  9. MASHAYEKHI M, Khalaji A, Malek Mahdavi A, Khabbazi A, et al
    Outcomes of undifferentiated peripheral inflammatory arthritis in real-world practice. A longitudinal cohort study.
    Clin Rheumatol. 2023;42:3143-3152.
    PubMed         Abstract available

  10. SANTOS CS, Salgueiro RR, Morales CM, Castro CA, et al
    Risk factors for cardiovascular disease in primary Sjogren's syndrome (pSS): a 20-year follow-up study.
    Clin Rheumatol. 2023;42:3021-3031.
    PubMed         Abstract available

  11. WISE L, Zell M
    Adult-onset Still's disease complicated by macrophage activation syndrome during pregnancy: a case-based review.
    Clin Rheumatol. 2023;42:3159-3166.
    PubMed         Abstract available


    J Rheumatol

  12. WIERCZEIKO A, Linke M, Friedrich JP, Koch J, et al
    A Call for Gene Expression Analysis in Whole Blood of Patients With Rheumatoid Arthritis (RA) as a Biomarker for RA-Associated Interstitial Lung Disease.
    J Rheumatol. 2024;51:130-133.
    PubMed         Abstract available

  13. KRISTENSEN S, Hagelskjaer AM, Cordtz R, Bliddal S, et al
    Polyautoimmunity in patients with anti-cyclic citrullinated peptide antibody-positive and -negative rheumatoid arthritis: a nationwide cohort study from Denmark.
    J Rheumatol. 2024 Feb 1:jrheum.2023-0907. doi: 10.3899/jrheum.2023-0907.
    PubMed         Abstract available

  14. GONZALEZ-GAY MA, Castaneda S, Ferraz-Amaro I
    Metabolic Syndrome: A Predisposing Factor for Rheumatoid Arthritis.
    J Rheumatol. 2024 Feb 1:jrheum.2023-1210. doi: 10.3899/jrheum.2023-1210.
    PubMed         Abstract available


    Rheumatol Int

  15. SCHAPINK L, den Broeder N, den Broeder AA, Verhoef LM, et al
    Treat-to-target vs fixed interval retreatment strategy with rituximab in rheumatoid arthritis: a retrospective cohort study.
    Rheumatol Int. 2024 Jan 29. doi: 10.1007/s00296-023-05524.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.